A Review of Systemic Treatment in Metastatic Triple-Negative Breast Cancer

Patients with breast cancer along with metastatic estrogen and progesterone receptor (ER/PR)- and human epidermal growth factor receptor 2 (HER2)-negative tumors are referred to as having metastatic triple-negative breast cancer (mTNBC) disease. Although there have been many new treatment options ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeichner, Simon B., Terawaki, Hiromi, Gogineni, Keerthi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807882/
https://www.ncbi.nlm.nih.gov/pubmed/27042088
http://dx.doi.org/10.4137/BCBCR.S32783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807882/
https://www.ncbi.nlm.nih.gov/pubmed/27042088
http://dx.doi.org/10.4137/BCBCR.S32783

Ejemplares similares